Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
quote
RVNC – Revance Therapeutics, Inc. –
RVNC – Revance Therapeutics, Inc. –
Quotes
Charts
News & Analysis for RVNC
Revance Therapeutics, Inc. (NASDAQ:RVNC) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
June 6, 2019
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
January 26, 2019
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
January 25, 2019
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
May 29, 2018
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Entry into a Material...
ME Staff 8-k
-
May 14, 2018
0
Analyst Activity – Mizuho Lowers Its Price Target On NASDAQ:RVNC –...
ME Staff
-
April 20, 2018
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Entry into a Material...
ME Staff 8-k
-
March 14, 2018
0
Analyst Activity – William Blair Reiterates Outperform on Revance Therapeutics (NASDAQ:RVNC)
ME Staff
-
March 1, 2018
0
Here’s What Just Happened With Revance Therapeutics Inc (NASDAQ: RVNC) and...
-
January 9, 2018
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Results of Operations and...
ME Staff 8-k
-
January 4, 2018
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Entry into a Material...
ME Staff 8-k
-
December 7, 2017
0
Biotech Data Watch: Galectin Therapeutics Inc (NASDAQ:GALT) and Revance Therapeutics, Inc....
-
December 6, 2017
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
December 5, 2017
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
September 6, 2017
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Results of Operations and...
ME Staff 8-k
-
August 3, 2017
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Financial Statements and Exhibits
ME Staff 8-k
-
August 2, 2017
0
Analyst Activity – Piper Jaffray Companies Reiterates Buy on Revance Therapeutics...
ME Staff
-
July 26, 2017
0
REVANCE THERAPEUTICS, INC. (NASDAQ:RVNC) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
June 6, 2017
0
Load more
